Wednesday, April 22, 2026
29.4 C
Bengaluru

5 L&D Megatrends

[wpfilebase tag=file id=86 tpl=download-button /]

Inside this Issue

1. Frontline Management: What Indian Pharma Needs to Get Right in 2017 by K. Hariram
10 pointers to get your FLM strategy right in the new year.

2. Embedding a Culture of Learning and Development in Pharma by Diksha Fouzdar
How pharma can make learning and development deliver real value to employees and become a part of the company’s DNA.

3. Emotional Marketing: From Fear to Love and Belonging by Vivek Hattangadi
Fear and Love are two of the most powerful of human emotions – here’s how pharma marketing can put them to use.

Hot this week

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

Topics

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img